InVivoMAb anti-human pan-Glypican
BE0412
ApplicationsFunctional Assay, Flow Cytometry, ImmunoPrecipitation, ELISA, Neutralisation/Blocking
Product group Antibodies
ReactivityHuman
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-human pan-Glypican
- Delivery Days Customer7
- ApplicationsFunctional Assay, Flow Cytometry, ImmunoPrecipitation, ELISA, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDHS20
- Concentration4-11 mg/ml
- Estimated Purity≥95% , Determined by SDS-PAGE
- HostHuman
- IsotypeIgG1
- ReactivityHuman
- Storage Instruction2°C to 8°C
- UNSPSC41116161
References
- Heparan sulfate promotes TRAIL-induced tumor cell apoptosis.Read this paper
- Tissue factor pathway inhibitor upregulates CXCR7 expression and enhances CXCL12-mediated migration in chronic lymphocytic leukemia.Read this paper
- R-spondins engage heparan sulfate proteoglycans to potentiate WNT signaling.Read this paper
- Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate.Read this paper
- Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells.Read this paper
- Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis.Read this paper
- Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy.Read this paper